Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Exelixis Inc (NQ: EXEL )

18.73 USD UNCHANGED
Streaming Delayed Price Updated: 7:55 PM EST, Nov 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 18.73
Bid (Size) 18.43 (1)
Ask (Size) 19.48 (5)
Prev. Close 18.73
Today's Range 18.73 - 18.73
52wk Range 13.67 - 27.80
Shares Outstanding 296,866,380
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in December
Exelixis, Inc. (Nasdaq: EXEL) today announced that members of the company’s management team will participate in fireside chats at the following virtual investor conferences in December: 
From Business Wire News Releases
Exelixis Announces Third Quarter 2020 Financial Results and Provides Corporate Update
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2020 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and... 
From Business Wire News Releases

Performance

YTD
+6.06%
+6.06%
1 Month
-13.49%
-13.49%
3 Month
-13.96%
-13.96%
6 Month
-23.02%
-23.02%
1 Year
+13.04%
+13.04%

More News

Read More
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
From Business Wire News Releases
Exelixis to Webcast Fireside Chats as Part of Virtual Investor Conferences in November
From Business Wire News Releases
EQAL's Holdings Imply 11% Gain Potential
Tags ETFs
From ETF Channel
Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) for the Treatment of Unresectable, Advanced or Metastatic Renal
From Business Wire News Releases
12 Healthcare Stocks Moving In Thursday's After-Market Session
Tags IRWD Market News DNLI
From Benzinga
Exelixis Announces First Patient Enrolled in Phase 1 Trial Cohort Evaluating XL092 in Combination with Atezolizumab in Patients with Advanced Solid Tumors
From Business Wire News Releases
Got $50? 4 Smart Stocks to Buy Into Right Now
Tags AUY Market News JUSHF
From Motley Fool
Exelixis to Release Third Quarter 2020 Financial Results on Thursday, November 5, 2020
From Business Wire News Releases
Exelixis Becomes Oversold (EXEL)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.